Your browser doesn't support javascript.
loading
Relaxin-2 plasma levels in atrial fibrillation are linked to inflammation and oxidative stress markers.
Aragón-Herrera, Alana; Couselo-Seijas, Marinela; Feijóo-Bandín, Sandra; Anido-Varela, Laura; Moraña-Fernández, Sandra; Tarazón, Estefanía; Roselló-Lletí, Esther; Portolés, Manuel; Martínez-Sande, José Luis; García-Seara, Javier; Álvarez, Ezequiel; González-Juanatey, José Ramón; Rodríguez-Mañero, Moisés; Eiras, Sonia; Lago, Francisca.
Afiliação
  • Aragón-Herrera A; Cellular and Molecular Cardiology Unit and Department of Cardiology, Institute of Biomedical Research of Santiago de Compostela (IDIS-SERGAS), Travesía da Choupana s/n, 15706, Santiago de Compostela, Spain.
  • Couselo-Seijas M; CIBERCV, Institute of Health Carlos III, C/ Monforte de Lemos 3-5, Pabellón 11, Planta 0, 28029, Madrid, Spain.
  • Feijóo-Bandín S; Translational Cardiology Group, Institute of Biomedical Research of Santiago de Compostela (IDIS-SERGAS), Travesía da Choupana s/n, 15706, Santiago de Compostela, Spain.
  • Anido-Varela L; Cellular and Molecular Cardiology Unit and Department of Cardiology, Institute of Biomedical Research of Santiago de Compostela (IDIS-SERGAS), Travesía da Choupana s/n, 15706, Santiago de Compostela, Spain.
  • Moraña-Fernández S; CIBERCV, Institute of Health Carlos III, C/ Monforte de Lemos 3-5, Pabellón 11, Planta 0, 28029, Madrid, Spain.
  • Tarazón E; Cellular and Molecular Cardiology Unit and Department of Cardiology, Institute of Biomedical Research of Santiago de Compostela (IDIS-SERGAS), Travesía da Choupana s/n, 15706, Santiago de Compostela, Spain.
  • Roselló-Lletí E; Cellular and Molecular Cardiology Unit and Department of Cardiology, Institute of Biomedical Research of Santiago de Compostela (IDIS-SERGAS), Travesía da Choupana s/n, 15706, Santiago de Compostela, Spain.
  • Portolés M; Cardiology Group, Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela and Health Research Institute, University Clinical Hospital of Santiago de Compostela, 15706, Santiago de Compostela, Spain.
  • Martínez-Sande JL; CIBERCV, Institute of Health Carlos III, C/ Monforte de Lemos 3-5, Pabellón 11, Planta 0, 28029, Madrid, Spain.
  • García-Seara J; Cardiocirculatory Unit, Health Institute La Fe University Hospital (IIS La Fe), Avda. de Fernando Abril Martorell 106, 46026, Valencia, Spain.
  • Álvarez E; CIBERCV, Institute of Health Carlos III, C/ Monforte de Lemos 3-5, Pabellón 11, Planta 0, 28029, Madrid, Spain.
  • González-Juanatey JR; Cardiocirculatory Unit, Health Institute La Fe University Hospital (IIS La Fe), Avda. de Fernando Abril Martorell 106, 46026, Valencia, Spain.
  • Rodríguez-Mañero M; CIBERCV, Institute of Health Carlos III, C/ Monforte de Lemos 3-5, Pabellón 11, Planta 0, 28029, Madrid, Spain.
  • Eiras S; Cardiocirculatory Unit, Health Institute La Fe University Hospital (IIS La Fe), Avda. de Fernando Abril Martorell 106, 46026, Valencia, Spain.
  • Lago F; CIBERCV, Institute of Health Carlos III, C/ Monforte de Lemos 3-5, Pabellón 11, Planta 0, 28029, Madrid, Spain.
Sci Rep ; 12(1): 22287, 2022 12 24.
Article em En | MEDLINE | ID: mdl-36566255

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Relaxina / Fibrilação Atrial / Estresse Oxidativo Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Relaxina / Fibrilação Atrial / Estresse Oxidativo Idioma: En Ano de publicação: 2022 Tipo de documento: Article